Eur J Cancer. 1990;26(5):593-6.

Early serum CA125 response and outcome in epithelial ovarian cancer.

Redman CW, Blackledge GR, Kelly K, Powell J, Buxton EJ, Luesley DM.

Source

Department of Obstetrics and Gynaecology, North Staffordshire Maternity Hospital, Stoke-on-Trent, U.K.

Abstract

The prognostic value of serum CA125 levels before and after two courses of chemotherapy was assessed in 50 patients with advanced epithelial ovarian cancer. Patients with serum CA125 values below 35 U/ml after two courses were significantly more likely to achieve complete remission and had a significantly longer median survival. In multivariate analysis, serum CA125 levels after two courses were the most important independent prognostic factor: it was possible to predict survival status at 12 months with an overall accuracy of 93%. Serum CA125 can be used to evaluate quantitatively chemotherapeutic response and at an early stage classify patients into good and poor risk groups. Such an approach would facilitate the selection of appropriate therapy and could reduce toxicity.

PMID:: 2144746; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Antigens, Tumor-Associated, Carbohydrate

LinkOut - more resources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer. [Int J Biol Markers. 2000]
Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer.
Colaković S, Lukiç V, Mitroviç L, Jeliç S, Susnjar S, Marinkoviç J. Int J Biol Markers. 2000 Apr-Jun; 15(2):147-52.
Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer. [J Surg Oncol. 1993]
Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer.
Hempling RE, Piver MS, Natarajan N, Baker TR, Thompson JM, Hicks ML, Mettlin CJ. J Surg Oncol. 1993 Sep; 54(1):38-44.
The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma. [Br J Cancer. 1993]
The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.
Fisken J, Leonard RC, Stewart M, Beattie GJ, Sturgeon C, Aspinall L, Roulston JE. Br J Cancer. 1993 Jul; 68(1):140-5.
Review A systematic overview of chemotherapy effects in ovarian cancer. [Acta Oncol. 2001]
Review A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T, Glimelius B, Nygren P, SBU-group. Swedish Council of Technology Assessment in Health Care. Acta Oncol. 2001; 40(2-3):340-60.
Review Medical therapy of advanced malignant epithelial tumours of the ovary. [Forum (Genova). 2000]
Review Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A. Forum (Genova). 2000 Oct-Dec; 10(4):323-32.

See reviews... See all...

Cited by 5 PubMed Central articles

Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature. [J Ovarian Res. 2009]
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature.
Gupta D, Lis CG. J Ovarian Res. 2009 Oct 9; 2:13. Epub 2009 Oct 9.
CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer. [Br J Cancer. 1999]
CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer.
Peters-Engl C, Obermair A, Heinzl H, Buxbaum P, Sevelda P, Medl M. Br J Cancer. 1999 Oct; 81(4):662-6.
CA 125 half-life in ovarian cancer: a multivariate survival analysis. [Br J Cancer. 1993]
CA 125 half-life in ovarian cancer: a multivariate survival analysis.
Yedema CA, Kenemans P, Voorhorst F, Bon G, Schijf C, Beex L, Verstraeten A, Hilgers J, Vermorken J. Br J Cancer. 1993 Jun; 67(6):1361-7.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Early serum CA125 response and outcome in epithelial ovarian cancer.
Early serum CA125 response and outcome in epithelial ovarian cancer.
Eur J Cancer. 1990 ;26(5):593-6.

PubMed
Squamous cell carcinoma in situ arising in mature cystic teratoma of the ovary: ...
Squamous cell carcinoma in situ arising in mature cystic teratoma of the ovary: a case report.
J Ovarian Res. 2011 Mar 24 ;4:5.

PubMed
Developmental pattern of the secretion of cumulus expansion-enabling factor by m...
Developmental pattern of the secretion of cumulus expansion-enabling factor by mouse oocytes and the role of oocytes in promoting granulosa cell differentiation.
Dev Biol. 1990 Aug ;140(2):307-17.

PubMed
Effects of GnRH agonist treatment on steroidogenesis and folliculogenesis in the...
Effects of GnRH agonist treatment on steroidogenesis and folliculogenesis in the ovary of cyclic mice.
J Ovarian Res. 2010 Nov 18 ;3:26.

PubMed
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for...
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt.
Development. 1990 Dec ;110(4):1001-20.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: